US4997770A - Method and means for detecting blood alcohol in humans by testing vapor above the eye - Google Patents

Method and means for detecting blood alcohol in humans by testing vapor above the eye Download PDF

Info

Publication number
US4997770A
US4997770A US07/151,306 US15130688A US4997770A US 4997770 A US4997770 A US 4997770A US 15130688 A US15130688 A US 15130688A US 4997770 A US4997770 A US 4997770A
Authority
US
United States
Prior art keywords
eye
ethanol
chamber
vapor
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US07/151,306
Inventor
Howel G. Giles
Yedy Israel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcoholism and Drug Addiction Research Foundation
Original Assignee
Alcoholism and Drug Addiction Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcoholism and Drug Addiction Research Foundation filed Critical Alcoholism and Drug Addiction Research Foundation
Assigned to ALCOHOLISM AND DRUG ADDICTION RESEARCH FOUNDATION reassignment ALCOHOLISM AND DRUG ADDICTION RESEARCH FOUNDATION ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: GILES, HOWEL G., ISRAEL, YEDY
Application granted granted Critical
Publication of US4997770A publication Critical patent/US4997770A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/90Breath testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/20Oxygen containing
    • Y10T436/203332Hydroxyl containing
    • Y10T436/204165Ethanol

Definitions

  • the present invention relates to the detection of alcohol in a human and more particularly to methods and means for such detection.
  • the patient may have vomited or regurgitated as a consequence of the accident with the same effect or so that the patient cannot apply the breathalyser tube to his mouth. Or the patient may be unconscious so that a breathalyser reading may not be feasible.
  • the blood alcohol level of the patient is determined by measuring the ethanol vapor emitted by the patient's eye. This vapor is not contaminated by any alcohol or vomit in the victim's mouth and can be sampled even when the victim is unconscious if the eye is kept open, for example with available sterile adhesive strips.
  • An eyepiece having a substantially impervious wall defining a chamber with lower and upper open ends, said lower open end having edge matchingly conformable with the adjacent face contour, said upper open end being shaped to receive in use an ethanol detecting sensor, in substantially sealed, spaced relation with an eye of a subject.
  • a method of detecting ethanol in lachrymal fluid which comprises enclosing an open eye of a subject in a chamber to define a space above the eye, introducing an ethanol vapor sensor into the space of the chamber in a spaced relation to the eye; calibrating said sensor; and measuring the ethanol vapor concentration in said lachrymal fluid exuded by the eye.
  • FIG. 1 is a general schematic view of a patient having blood alcohol level determined in accordance with the invention.
  • FIG. 2 is a general perspective view of an eyepiece in accordance with the present invention.
  • FIG. 3 is a block diagram of a circuit employed in the present invention.
  • FIG. 4 is a schematic diagram of the circuit of FIG. 3.
  • FIG. 5 is a diagram of illustrating the concentration of ethanol/time profile by gas chromatographic analysis of blood, and eye vapor analysis, respectively, in normal rats.
  • FIG. 6 is a diagram illustrating the concentration of ethanol/time profile by gas chromatographic analysis of blood, and eye vapour analysis, respectively, in ethanol-treated rats.
  • FIG. 7 is a diagram illustrating the concurrence between the ethanol concentration in blood and lachrymal fluid in three male Sprague-Dawley rats.
  • FIG. 8 is a diagram comparing the ethanol concentration/time in plasma (circles) and lachrymal fluid (squares) after ethanol administration to 4 New Zealand white rabbits.
  • FIG. 9 is a diagram of a standard curve illustrating the correlation between plasma concentration of ethanol and eye vapor response in millivolts with the basal millivolt response substracted.
  • FIG. 10 is a diagram illustrating the ethanol concentration/time in plasma obtained by gas chromatography (circles) and by eye vapor analysis (squares) in 4 New Zealand white rabbits.
  • FIG. 11 is a diagram illustrating the relationship between a 15 second millivolt response on the eye and blood ethanol when measured in accordance with the present invention.
  • FIG. 12 is a diagram illustrating the relationship between breath alcohol and blood ethanol employing a conventional breathalyser machine.
  • FIG. 13 is a diagram illustrating the relationship between blood ethanol level/time as measured by gas chromatography in the blood (circles) and in the breath as measured by breathalyser (squares);
  • FIG. 14 is a diagram illustrating the relationship between blood ethanol level/time as measured by gas chromatography (circles) and in the eye vapor as measured by the method of the present invention.
  • the method of the present invention provides a non-invasive passive technique for determining the alcohol level in the subject's body fluids through a determination of the alcohol in the eye vapor.
  • the only important factor is that the eye of the subject be open.
  • the eye vapor is not subject to contamination by mouth alcohol or by stomach gases due to regurgitation, as is the case with the breathalyser technique.
  • the method may be applied when the patient is unconscious or not capable of taking any objects into the mouth.
  • an eyepiece 9 in the embodiment employed is a transparent plastic wall 10 having open upper and lower edges 11 and 12 defining openings.
  • a cushion 13 is provided around lower edge 12 . It will be observed that the lower edge 12 is relieved at substantially opposed sides 20 and 21 to conform with the adjacent cheek and nose surfaces with which it may come into contact. It will also be noted that this configuration permits use on either the right or left eye.
  • a vapor sensor 15 is inserted through the upper opening 11 and held there so that it is spaced away from the adjacent eye surface. The spacing from the eye surface has been found to lead to a "cleaner" signal with less extraneous "noise".
  • the circuit employed comprises a vapor sensor such as a Type 812 Figaro gas sensor indicated at 15.
  • the output of sensor 15 is connected through a pair of amplifiers 17 and 18 to an analog to digital converter 19, the output of the converter is connected to a microprocessor 20, and in turn to a digital display 21.
  • the senor 16 is suitably calibrated prior to use. This may be provided by a reference sensor circuit depending upon the experimental conditions.
  • lachrymal fluid should also contain ethanol at the same concentration as the remaining body fluid and since, according to Henry's law the concentration of ethanol in the vapor phase is proportional to the concentration of ethanol in the liquid phase a determination of ethanol in the lachrymal eye vapor would give an indication of the alcohol concentration in the subject's body fluids.
  • the millivolt response from the eye was compared with a standard curve obtained from aqueous ethanol solutions.
  • the standard curve was obtained from a correlation of the log of the concentrations and the millivolt response measured above 1 ml solutions in 20 ml scintillation vials at 29.5° C. The concentrations obtained from this calculation were multiplied by 0.85 to account for the differences in water content between blood and pure water.
  • Blood ethanol concentration was determined by head space gas chromatography by methods known in the art.
  • the ratio of ethanol concentrations in the two fluids is given by the slope of the correlation or the reciprocal of the slope.
  • the reciprocal of the slope is the same as the ratio of the water contents of lachrymal fluid (approximately 100%) and blood (85% for humans).
  • Ethanol concentrations were determined either by known injection gas chromatography or by head space gas chromatography techniques.
  • the eyepiece 9 For the ethanol vapor determination eyepiece 9 was used to hold the sensor in position, the eyepiece had a volume of approximately 24 mL. For the measurements, the sensor was placed in the top of the eyepiece (leaving a volume of 23 mL.) and the bottom edge was placed around the eye of the rabbit. The sensor was activated for 30 seconds after which time the millivolt response was noted.
  • the results of the first two rabbits studied were used to calculate plasma concentrations from ethanol eye vapor responses in the other four animals.
  • the standard curve (FIG. 9) was obtained by correlating points of the linear portion of the ethanol plasma concentration versus time curves with the coincident eye vapor responses that were measured in millivolts. This standard curve was then used for the other four rabbits to give estimated plasma concentrations from the eye measurements. A comparison of the actual plasma concentrations and estimated plasma concentrations is shown in FIG. 10.
  • the blood ethanol level, breath alcohol level and eye vapor alcohol level were determined. In the case of blood ethanol at hourly intervals and in the latter two cases at half-hourly intervals in the same manner as previously described in Examples I and II.
  • the blood ethanol level was determined by gas chromatography; the breath alcohol level was determined using a breathalyser (A.L.E.R.T. model manufactured by Alcohol Countermeasures Inc.)
  • the eye vapor this was accomplished by holding the sensor eyepiece over the subject's open eye, with the eyepiece edges in contact with the subject's face for fifteen seconds and the fifteen second millivolt response was obtained. The results are shown in FIGS. 11, 12, 13 and 14.

Abstract

A method of detecting ethanol in lachrymal fluid is provided in which an open eye of a subject is enclosed in a chamber to define a space above the eye, an ethanol vapor sensor is introduced into the space of the chamber in a spaced relation to the eye; the sensor is calibrated; and the ethanol vapor concentration in the said lachrymal fluid exuded by the eye is measured.

Description

BACKGROUND OF THE INVENTION
The present invention relates to the detection of alcohol in a human and more particularly to methods and means for such detection.
The detection of blood alcohol levels in human beings has been achieved by various methods and for different purposes.
For law enforcement the determination of blood alcohol levels has been essential for the prosecution of various offences particularly highway driving offences where the suspect may be impaired.
For general medical purposes it is frequently essential for the physicians to make an objective determination of the alcohol blood level of a patient to determine the health of the patient and/or the appropriate treatment.
Sometimes the purposes overlap such as in a highway traffic accident However, irrespective of the purposes, in the latter situation where the patient is critically ill the measurement of the alcohol blood level is by present methods time consuming and requires considerable expertise and is not possible without invasive methods.
The obtaining of a blood alcohol reading by the breathalyser technique will not give an accurate reading if the patient has only just finished consuming alcohol: the alcohol in the mouth distorts the reading.
The patient may have vomited or regurgitated as a consequence of the accident with the same effect or so that the patient cannot apply the breathalyser tube to his mouth. Or the patient may be unconscious so that a breathalyser reading may not be feasible.
The other present methods and equipment are more cumbersome and awkward to use so that they are, for the purpose of the present discussion irrelevant.
SUMMARY OF THE PRESENT INVENTION
Accordingly, it is an object of the present invention to provide a method and apparatus which enables the blood alcohol level in a patient to be determined objectively and independently of the remaining physical conditions of the patient.
It is a feature of the invention that the blood alcohol level of the patient is determined by measuring the ethanol vapor emitted by the patient's eye. This vapor is not contaminated by any alcohol or vomit in the victim's mouth and can be sampled even when the victim is unconscious if the eye is kept open, for example with available sterile adhesive strips.
There is therefore provided in accordance with the present invention:
An eyepiece having a substantially impervious wall defining a chamber with lower and upper open ends, said lower open end having edge matchingly conformable with the adjacent face contour, said upper open end being shaped to receive in use an ethanol detecting sensor, in substantially sealed, spaced relation with an eye of a subject.
There is also provided in accordance with present invention, a method of detecting ethanol in lachrymal fluid which comprises enclosing an open eye of a subject in a chamber to define a space above the eye, introducing an ethanol vapor sensor into the space of the chamber in a spaced relation to the eye; calibrating said sensor; and measuring the ethanol vapor concentration in said lachrymal fluid exuded by the eye.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a general schematic view of a patient having blood alcohol level determined in accordance with the invention.
FIG. 2 is a general perspective view of an eyepiece in accordance with the present invention.
FIG. 3 is a block diagram of a circuit employed in the present invention.
FIG. 4 is a schematic diagram of the circuit of FIG. 3.
FIG. 5 is a diagram of illustrating the concentration of ethanol/time profile by gas chromatographic analysis of blood, and eye vapor analysis, respectively, in normal rats.
FIG. 6 is a diagram illustrating the concentration of ethanol/time profile by gas chromatographic analysis of blood, and eye vapour analysis, respectively, in ethanol-treated rats.
FIG. 7 is a diagram illustrating the concurrence between the ethanol concentration in blood and lachrymal fluid in three male Sprague-Dawley rats.
FIG. 8 is a diagram comparing the ethanol concentration/time in plasma (circles) and lachrymal fluid (squares) after ethanol administration to 4 New Zealand white rabbits.
FIG. 9 is a diagram of a standard curve illustrating the correlation between plasma concentration of ethanol and eye vapor response in millivolts with the basal millivolt response substracted.
FIG. 10 is a diagram illustrating the ethanol concentration/time in plasma obtained by gas chromatography (circles) and by eye vapor analysis (squares) in 4 New Zealand white rabbits.
FIG. 11 is a diagram illustrating the relationship between a 15 second millivolt response on the eye and blood ethanol when measured in accordance with the present invention.
FIG. 12 is a diagram illustrating the relationship between breath alcohol and blood ethanol employing a conventional breathalyser machine.
FIG. 13 is a diagram illustrating the relationship between blood ethanol level/time as measured by gas chromatography in the blood (circles) and in the breath as measured by breathalyser (squares); and
FIG. 14 is a diagram illustrating the relationship between blood ethanol level/time as measured by gas chromatography (circles) and in the eye vapor as measured by the method of the present invention.
As illustrated in FIG. 1 the method of the present invention provides a non-invasive passive technique for determining the alcohol level in the subject's body fluids through a determination of the alcohol in the eye vapor.
The only important factor is that the eye of the subject be open. The eye vapor is not subject to contamination by mouth alcohol or by stomach gases due to regurgitation, as is the case with the breathalyser technique.
It is also apparent that the method may be applied when the patient is unconscious or not capable of taking any objects into the mouth.
As shown in FIG. 2 an eyepiece 9 in the embodiment employed is a transparent plastic wall 10 having open upper and lower edges 11 and 12 defining openings. Around lower edge 12 a cushion 13 is provided. It will be observed that the lower edge 12 is relieved at substantially opposed sides 20 and 21 to conform with the adjacent cheek and nose surfaces with which it may come into contact. It will also be noted that this configuration permits use on either the right or left eye.
It will also be observed from FIG. 1 that a vapor sensor 15 is inserted through the upper opening 11 and held there so that it is spaced away from the adjacent eye surface. The spacing from the eye surface has been found to lead to a "cleaner" signal with less extraneous "noise".
As illustrated in FIGS. 3 and 4 the circuit employed comprises a vapor sensor such as a Type 812 Figaro gas sensor indicated at 15. The output of sensor 15 is connected through a pair of amplifiers 17 and 18 to an analog to digital converter 19, the output of the converter is connected to a microprocessor 20, and in turn to a digital display 21.
It will of course be understood that the sensor 16 is suitably calibrated prior to use. This may be provided by a reference sensor circuit depending upon the experimental conditions.
While it is recognized that intact excretion of ethanol takes places through urine and in vapor form through the breath, it was postulated that since ethanol was distributed throughout the total body water, lachrymal fluid should also contain ethanol at the same concentration as the remaining body fluid and since, according to Henry's law the concentration of ethanol in the vapor phase is proportional to the concentration of ethanol in the liquid phase a determination of ethanol in the lachrymal eye vapor would give an indication of the alcohol concentration in the subject's body fluids.
The invention will be more fully understood by reference to the following Examples and experiments.
EXAMPLE I Normal Rats-Eye Vapor Response
Male, Sprague-Dawley rats, weight 288 ±9 g, mean± s.e.m., were given ethanol, 1 g/kg, by gavage, as a 13% solution in water. Blood samples (0.05 ml) and eye vapor measurements were taken over four hours after ethanol administration. The results are illustrated in FIG. 5.
Ethanol Treated Rats
These animals had been fed on an ethanol-containing liquid diet for 4 weeks for different experimental purposes in our laboratory and were withdrawn from ethanol 5 days before the study. The rats, weight 274±12 g were given ethanol orally on the day of the study as above. Blood samples and eye vapor measurements were taken over three hours. The results are illustrated in FIG. 6.
Calculation of Blood Alcohol Concentration from Eye Vapor Response
The millivolt response from the eye was compared with a standard curve obtained from aqueous ethanol solutions. The standard curve was obtained from a correlation of the log of the concentrations and the millivolt response measured above 1 ml solutions in 20 ml scintillation vials at 29.5° C. The concentrations obtained from this calculation were multiplied by 0.85 to account for the differences in water content between blood and pure water.
Normal Rats-Lachrymal Fluid
Male, Sprague-Dawley rats, weighing 250-270 g were given ethanol as above. Blood samples (9.57 μl) were taken from the tail vein and added to saturated salt water (250 μl) in a head space vial. Lachrymal fluid samples (typically 3 μl) were obtained in a capillary tube (5 μl) while the animals were under ketamine anesthesia (80 mg/kg, intramuscularly, plus 15 mg/kg as needed). The exact volumes of these samples were determined from the length of liquid in the capillary tubes. These samples were also added to saturated salt water in a head space vial. The samples were obtained from 1 to 4 hours after ethanol administration.
Determination of Tail Vein Blood and Lachrymal Fluid Ethanol Concentrations
Blood ethanol concentration was determined by head space gas chromatography by methods known in the art.
Calculation of Metabolic Rates
The rectilinear portions of the plasma ethanol concentration versus time profiles were identified from the individual plots. Least squares regression analyses yielded the intercepts on the abscissae which were divided by the dose to give ethanol metabolic rates in mg/kg/hr.
The concentration versus time profiles are shown in FIGS. 5 and 6. It will be apparent that throughout the study periods, there is good agreement between the concentrations of ethanol obtained by gas chromatographic analysis of blood and by eye vapor analysis. As a consequence, the metabolic parameters obtained by the two methods for the groups of animals are also in good agreement. For the normal rats, the metabolic rates were calculated to be 241±7 and 234±9 (s.e.m.) mg/kg/hr by blood and eye vapor analysis, respectively. For the ethanol treated animals the comparable results were 318±7 and 302±13 mg/kg/hr. Using all of the individual data points, the correlation of blood ethanol concentrations obtained by the two methods yields: correlation coefficient=0.92, slope=0.99, intercept=4.2 mg/dl, n=61, range 0-98 mg/dl.
The correlation of ethanol concentration in blood and lacrimal fluid are shown in FIG. 7 where correlation co-efficient=0.99, slope=1.18, 1/slope=0.85, intercept=-5.0 mg/dl, n=12. The ratio of ethanol concentrations in the two fluids is given by the slope of the correlation or the reciprocal of the slope. The reciprocal of the slope is the same as the ratio of the water contents of lachrymal fluid (approximately 100%) and blood (85% for humans).
EXAMPLE II Rabbits: First Study
Four, male, New Zealand White rabbits received ethanol (6 g/kg) by an intravenous bolus in a marginal ear vein. Heparinized blood samples (0.1 mL) were obtained from the opposite ear and centrifuged to yield plasma. Samples (0.01 mL) of lachrymal secretion were collected by micropipette from the lower conjunctival sac. The times of the samples as indicated in FIG. 8 were taken over 5 hours.
Analysis of Ethanol in Plasma and Lachrymal Fluid
Ethanol concentrations were determined either by known injection gas chromatography or by head space gas chromatography techniques.
Rabbits: Second Study
Six, male, New Zealand White rabbits received ethanol (about 750 mg/kg, Table 1) by an intravenous bolus in a marginal ear vein. Blood samples and 30 second eye measurements were taken over 3.5 hours as indicated in FIG. 10.
Analysis of Ethanol in Vapor
For the ethanol vapor determination eyepiece 9 was used to hold the sensor in position, the eyepiece had a volume of approximately 24 mL. For the measurements, the sensor was placed in the top of the eyepiece (leaving a volume of 23 mL.) and the bottom edge was placed around the eye of the rabbit. The sensor was activated for 30 seconds after which time the millivolt response was noted.
Calculation of Plasma Concentration From Eye Measurements
The results of the first two rabbits studied were used to calculate plasma concentrations from ethanol eye vapor responses in the other four animals. The standard curve (FIG. 9) was obtained by correlating points of the linear portion of the ethanol plasma concentration versus time curves with the coincident eye vapor responses that were measured in millivolts. This standard curve was then used for the other four rabbits to give estimated plasma concentrations from the eye measurements. A comparison of the actual plasma concentrations and estimated plasma concentrations is shown in FIG. 10.
Calculation of Metabolic Parameters
The rectilinear portions of the plasma ethanol concentration versus time profiles were identified from the individual plots. Least squares regression analyses yielded the slopes of the lines and intercepts on the abscissae. The slopes gave the clearances of ethanol in mg/dL/h while the abscissae were divided by the doses to give ethanol metabolic rates in mg/Kg/h. These results are shown in Table 1 below.
                                  TABLE 1                                 
__________________________________________________________________________
Comparison of metabolic parameters derived by the two methods             
Rabbit       GC plasma analysis                                           
                           Eye ethanol vapor analysis                     
    Weight                                                                
        Dose -Slope                                                       
                   Metabolic rate                                         
                           -Slope                                         
                                 Metabolic rate                           
No. (kg)                                                                  
        (mg/Kg)                                                           
             (mg/dL/h)                                                    
                   (mb/Kg/h)                                              
                           (mg/dL/h)                                      
                                 (mg/Kg/h)                                
__________________________________________________________________________
3   2.5 754  29.7  234     21.2  200                                      
4   2.6 750  29.3  234     25.9  217                                      
5   2.4 771  31.4  232     30.9  207                                      
6   3.2 808  25.6  207     26.5  215                                      
Mean         29.0  226     26.1  210                                      
S.D.          2.4   13      4.0   8                                       
__________________________________________________________________________
EXAMPLE III
Six alcoholic liver disease patients were given 0.5 g/Kg of ethanol intravenously over 45 minutes.
The blood ethanol level, breath alcohol level and eye vapor alcohol level were determined. In the case of blood ethanol at hourly intervals and in the latter two cases at half-hourly intervals in the same manner as previously described in Examples I and II. The blood ethanol level was determined by gas chromatography; the breath alcohol level was determined using a breathalyser (A.L.E.R.T. model manufactured by Alcohol Countermeasures Inc.) In the case of the eye vapor this was accomplished by holding the sensor eyepiece over the subject's open eye, with the eyepiece edges in contact with the subject's face for fifteen seconds and the fifteen second millivolt response was obtained. The results are shown in FIGS. 11, 12, 13 and 14.
It will be observed that the correlation between the eye vapor results and the breathalyser results in these various experiments indicate that a more accurate result than the breath test and results which are statistically acceptable and comparable with gas chromatography without the attendant awkwardness and difficulty.

Claims (20)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. A method of detecting ethanol in lachrymal fluid which comprises enclosing an open eye of a subject in a chamber to define a space above the eye, providing an ethanol vapor sensor into the space of the chamber in a spaced relation to the eye; calibrating said sensor; and measuring the ethanol concentration in space above said lachrymal fluid exuded by the eye.
2. The method of claim 1 wherein said measuring step follows said enclosing step by a time sufficient for the concentration of alcohol in the vapors within said chamber to relate to the concentration of alcohol in the liquid lachrymal fluid of said eye in accordance with Henry'law.
3. The method of claim 1 further comprising the initial step of restraining said eye in an open state.
4. The method of claim 1 wherein said enclosing step includes the step of sealing an eyepiece against the face of said subject.
5. An apparatus for detecting alcohol levels in humans comprising:
an eyepiece contoured to form a vapor confining chamber over the eye of a human subject; and
an ethanol detecting sensor connected to said eyepiece to sample vapor from within said chamber.
6. The apparatus of claim 5 further comprising:
means connected to said sensor for comparing said measured ethanol content with a reference to determine the blood alcohol level of said human subject.
7. The apparatus of claim 5 wherein said eyepiece has a substantially vapor impervious wall defining a chamber with lower and upper open ends, said lower open end having an edge conformable with the face contour of the subject, said upper open end being shaped to receive in use the ethanol detecting sensor, in substantially sealed spaced relation with the eye of the subject.
8. An apparatus as claimed in claim 7 wherein said wall defines a frusto-conical chamber.
9. An apparatus as claimed in claim 7 wherein said lower end of said wall has a cushion mounted therearound.
10. A method of determining the blood alcohol level of a person comprising the steps of:
sampling vapors of lachrymal fluid from an eye of said person; and
measuring the ethanol vapor content of said sampled lachrymal fluid vapor.
11. The method of claim 10 further comprising the step of:
comparing said measured ethanol content with a reference to determine the blood alcohol level of said person.
12. The method of claim 10 further comprising the step of:
enclosing a chamber about said eye of said person to define a confined space adjacent said eye, said sampling step including the step of sampling said vapors from a gas within said confined space.
13. The method of claim 12 wherein said eye is open.
14. The method of claim 12 further comprising the initial step of restraining said eye in an open state.
15. The method of claim 12 wherein said measuring step follows said enclosing step by a time sufficient for the concentration of alcohol of the vapors within said chamber to relate to the concentration in alcohol in the liquid lachrymal fluid of said eye in accordance with Henry's law.
16. The method of claim 15 wherein said time is at least approximately fifteen seconds.
17. The method of claim 15 wherein said eye is open.
18. The method of claim 12 wherein said chamber is enclosed with an eyepiece having an open end, and with a portion of the face of said person which includes said eye of said person closing said open end.
19. The method of claim 18 wherein said eye is open.
20. The method of claim 18 wherein said eyepiece is a tube having a second open end and said chamber is further formed by closing said second open end with structure which includes an ethanol detecting sensor, said measuring step being performed with said sensor.
US07/151,306 1987-05-26 1988-02-01 Method and means for detecting blood alcohol in humans by testing vapor above the eye Expired - Fee Related US4997770A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA000538052A CA1305873C (en) 1987-05-26 1987-05-26 Method and means for detecting alcohol levels in humans
CA538,052 1987-05-26

Publications (1)

Publication Number Publication Date
US4997770A true US4997770A (en) 1991-03-05

Family

ID=4135750

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/151,306 Expired - Fee Related US4997770A (en) 1987-05-26 1988-02-01 Method and means for detecting blood alcohol in humans by testing vapor above the eye

Country Status (5)

Country Link
US (1) US4997770A (en)
EP (1) EP0293169B1 (en)
JP (1) JPS6476832A (en)
CA (1) CA1305873C (en)
DE (1) DE3880372T2 (en)

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5220919A (en) * 1991-08-23 1993-06-22 Safety Technology Partners, Ltd. Blood alcohol monitor
US5496740A (en) * 1991-09-04 1996-03-05 Lion Laboratories Plc Method and apparatus for determining the concentration of components of liquid systems
US5659126A (en) * 1996-04-19 1997-08-19 Farber; Milton Gas chromatograph techniques for on-line testing of transformer faults
US5729619A (en) * 1995-08-08 1998-03-17 Northrop Grumman Corporation Operator identity, intoxication and drowsiness monitoring system and method
US5969615A (en) * 1993-04-22 1999-10-19 Ivey, Jr.; Ellwood G. System for monitoring and encumbering use of a hand-operated machine by an impaired individual through detection of toxins in the individual
US20060179939A1 (en) * 2005-02-11 2006-08-17 Landon Duval Sensor enclosure with vestibule and opposing apertures
US20140132957A1 (en) * 2010-07-09 2014-05-15 Methode Electronics, Inc. Optical measurement of an analyte
US8798332B2 (en) 2012-05-15 2014-08-05 Google Inc. Contact lenses
US8821811B2 (en) 2012-09-26 2014-09-02 Google Inc. In-vitro contact lens testing
US8820934B1 (en) 2012-09-05 2014-09-02 Google Inc. Passive surface acoustic wave communication
US8857981B2 (en) 2012-07-26 2014-10-14 Google Inc. Facilitation of contact lenses with capacitive sensors
US8874182B2 (en) 2013-01-15 2014-10-28 Google Inc. Encapsulated electronics
US8870370B1 (en) 2012-09-24 2014-10-28 Google Inc. Contact lens that facilitates antenna communication via sensor impedance modulation
US8880139B1 (en) 2013-06-17 2014-11-04 Google Inc. Symmetrically arranged sensor electrodes in an ophthalmic electrochemical sensor
US8919953B1 (en) 2012-08-02 2014-12-30 Google Inc. Actuatable contact lenses
US8926809B2 (en) 2013-01-25 2015-01-06 Google Inc. Standby biasing of electrochemical sensor to reduce sensor stabilization time during measurement
US8950068B2 (en) 2013-03-26 2015-02-10 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US8965478B2 (en) 2012-10-12 2015-02-24 Google Inc. Microelectrodes in an ophthalmic electrochemical sensor
US8960899B2 (en) 2012-09-26 2015-02-24 Google Inc. Assembling thin silicon chips on a contact lens
US8960898B1 (en) 2012-09-24 2015-02-24 Google Inc. Contact lens that restricts incoming light to the eye
US8979271B2 (en) 2012-09-25 2015-03-17 Google Inc. Facilitation of temperature compensation for contact lens sensors and temperature sensing
US8985763B1 (en) 2012-09-26 2015-03-24 Google Inc. Contact lens having an uneven embedded substrate and method of manufacture
US8989834B2 (en) 2012-09-25 2015-03-24 Google Inc. Wearable device
US9009958B2 (en) 2013-03-27 2015-04-21 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US9028772B2 (en) 2013-06-28 2015-05-12 Google Inc. Methods for forming a channel through a polymer layer using one or more photoresist layers
US9063351B1 (en) 2012-09-28 2015-06-23 Google Inc. Input detection system
US9111473B1 (en) 2012-08-24 2015-08-18 Google Inc. Input system
US9158133B1 (en) 2012-07-26 2015-10-13 Google Inc. Contact lens employing optical signals for power and/or communication
US9176332B1 (en) 2012-10-24 2015-11-03 Google Inc. Contact lens and method of manufacture to improve sensor sensitivity
US9184698B1 (en) 2014-03-11 2015-11-10 Google Inc. Reference frequency from ambient light signal
US9289954B2 (en) 2013-01-17 2016-03-22 Verily Life Sciences Llc Method of ring-shaped structure placement in an eye-mountable device
US9298020B1 (en) 2012-07-26 2016-03-29 Verily Life Sciences Llc Input system
US9307901B1 (en) 2013-06-28 2016-04-12 Verily Life Sciences Llc Methods for leaving a channel in a polymer layer using a cross-linked polymer plug
US9320460B2 (en) 2012-09-07 2016-04-26 Verily Life Sciences Llc In-situ tear sample collection and testing using a contact lens
US9326710B1 (en) 2012-09-20 2016-05-03 Verily Life Sciences Llc Contact lenses having sensors with adjustable sensitivity
US9332935B2 (en) 2013-06-14 2016-05-10 Verily Life Sciences Llc Device having embedded antenna
US9366570B1 (en) 2014-03-10 2016-06-14 Verily Life Sciences Llc Photodiode operable in photoconductive mode and photovoltaic mode
US9398868B1 (en) 2012-09-11 2016-07-26 Verily Life Sciences Llc Cancellation of a baseline current signal via current subtraction within a linear relaxation oscillator-based current-to-frequency converter circuit
US9492118B1 (en) 2013-06-28 2016-11-15 Life Sciences Llc Pre-treatment process for electrochemical amperometric sensor
US9523865B2 (en) 2012-07-26 2016-12-20 Verily Life Sciences Llc Contact lenses with hybrid power sources
US9572522B2 (en) 2013-12-20 2017-02-21 Verily Life Sciences Llc Tear fluid conductivity sensor
US9636016B1 (en) 2013-01-25 2017-05-02 Verily Life Sciences Llc Eye-mountable devices and methods for accurately placing a flexible ring containing electronics in eye-mountable devices
US9654674B1 (en) 2013-12-20 2017-05-16 Verily Life Sciences Llc Image sensor with a plurality of light channels
US9685689B1 (en) 2013-06-27 2017-06-20 Verily Life Sciences Llc Fabrication methods for bio-compatible devices
US9696564B1 (en) 2012-08-21 2017-07-04 Verily Life Sciences Llc Contact lens with metal portion and polymer layer having indentations
US9757056B1 (en) 2012-10-26 2017-09-12 Verily Life Sciences Llc Over-molding of sensor apparatus in eye-mountable device
US9789655B1 (en) 2014-03-14 2017-10-17 Verily Life Sciences Llc Methods for mold release of body-mountable devices including microelectronics
US9814387B2 (en) 2013-06-28 2017-11-14 Verily Life Sciences, LLC Device identification
US9884180B1 (en) 2012-09-26 2018-02-06 Verily Life Sciences Llc Power transducer for a retinal implant using a contact lens
US9948895B1 (en) 2013-06-18 2018-04-17 Verily Life Sciences Llc Fully integrated pinhole camera for eye-mountable imaging system
US9965583B2 (en) 2012-09-25 2018-05-08 Verily Life Sciences, LLC Information processing method
US10010270B2 (en) 2012-09-17 2018-07-03 Verily Life Sciences Llc Sensing system
US10799421B2 (en) 2016-03-09 2020-10-13 Equinox Ophthalmic, Inc. Therapeutic eye treatment with gases
US20220096405A1 (en) * 2015-12-07 2022-03-31 General Oncology, Inc. Combination Therapy for Metastatic Cancer

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113567579B (en) * 2021-07-16 2022-08-23 江南大学 Method for evaluating metabolic rate and comfort degree of beverage after drinking

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2506175A1 (en) * 1975-02-14 1976-08-26 Draegerwerk Ag Blood alcohol measurement - by percutaneous sampling and measuring device
US4220158A (en) * 1977-11-15 1980-09-02 The Medishield Corporation Limited Transcutaneous probe
US4401122A (en) * 1979-08-02 1983-08-30 Children's Hospital Medical Center Cutaneous methods of measuring body substances
US4461303A (en) * 1982-04-28 1984-07-24 Eye Research Institute Of Retina Foundation Non-intrusive tear evaporimeter
US4597392A (en) * 1983-04-12 1986-07-01 Max Planck Gesellschaft Arrangement for measuring diffusing particles
US4809698A (en) * 1986-12-05 1989-03-07 Sumitomo Electric Industries, Ltd. Transcutaneous blood gas sensor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB718747A (en) * 1952-07-22 1954-11-17 Nat Res Dev A device for examining the eye
GB782295A (en) * 1955-04-04 1957-09-04 Clement Clarke Ltd Improvements in or relating to light transmitting elements for use in gonioscopy
US3649199A (en) * 1970-03-26 1972-03-14 Varian Associates Method for detecting trace quantities of an organic drug material in a living animal
US3963019A (en) * 1974-11-25 1976-06-15 Quandt Robert S Ocular testing method and apparatus

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2506175A1 (en) * 1975-02-14 1976-08-26 Draegerwerk Ag Blood alcohol measurement - by percutaneous sampling and measuring device
US4220158A (en) * 1977-11-15 1980-09-02 The Medishield Corporation Limited Transcutaneous probe
US4401122A (en) * 1979-08-02 1983-08-30 Children's Hospital Medical Center Cutaneous methods of measuring body substances
US4461303A (en) * 1982-04-28 1984-07-24 Eye Research Institute Of Retina Foundation Non-intrusive tear evaporimeter
US4597392A (en) * 1983-04-12 1986-07-01 Max Planck Gesellschaft Arrangement for measuring diffusing particles
US4809698A (en) * 1986-12-05 1989-03-07 Sumitomo Electric Industries, Ltd. Transcutaneous blood gas sensor

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
Giles et al., "Ethanol Vapours Above Lacrinal Fluid in the Rabbit" Canadian Journal of Physiology and Pharmacology, 12/87, pp. 2491-2493.
Giles et al., "Measuring Alcohol In Vapours Above The Eye", The Lancet, 9/5/87, pp. 580-581.
Giles et al., "Noninvasive Estimation of Blood Alcohol Concentrations: Ethanol Vapor Above The Eye", Alcoholism Clinical & Exp. Res., vol. 12, No. 2, Mar./Apr. 1988.
Giles et al., Alcohol Clin. Exp. Res. 12(2) 1988. pp. 255 258. *
Giles et al., Alcohol Clin. Exp. Res. 12(2) 1988. pp. 255-258.
Giles et al., Can. J. Physiol. Pharmacol. 65 (12), 1987. pp. 2491 2493. *
Giles et al., Can. J. Physiol. Pharmacol. 65 (12), 1987. pp. 2491-2493.
Giles et al., Ethanol Vapours Above Lacrinal Fluid in the Rabbit Canadian Journal of Physiology and Pharmacology, 12/87, pp. 2491 2493. *
Giles et al., Measuring Alcohol In Vapours Above The Eye , The Lancet, 9/5/87, pp. 580 581. *
Giles et al., Noninvasive Estimation of Blood Alcohol Concentrations: Ethanol Vapor Above The Eye , Alcoholism Clinical & Exp. Res., vol. 12, No. 2, Mar./Apr. 1988. *

Cited By (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5220919A (en) * 1991-08-23 1993-06-22 Safety Technology Partners, Ltd. Blood alcohol monitor
US5496740A (en) * 1991-09-04 1996-03-05 Lion Laboratories Plc Method and apparatus for determining the concentration of components of liquid systems
US5969615A (en) * 1993-04-22 1999-10-19 Ivey, Jr.; Ellwood G. System for monitoring and encumbering use of a hand-operated machine by an impaired individual through detection of toxins in the individual
US5729619A (en) * 1995-08-08 1998-03-17 Northrop Grumman Corporation Operator identity, intoxication and drowsiness monitoring system and method
US5659126A (en) * 1996-04-19 1997-08-19 Farber; Milton Gas chromatograph techniques for on-line testing of transformer faults
US20060179939A1 (en) * 2005-02-11 2006-08-17 Landon Duval Sensor enclosure with vestibule and opposing apertures
US20140132957A1 (en) * 2010-07-09 2014-05-15 Methode Electronics, Inc. Optical measurement of an analyte
US8798332B2 (en) 2012-05-15 2014-08-05 Google Inc. Contact lenses
US9047512B2 (en) 2012-05-15 2015-06-02 Google Inc. Contact lenses
US10873401B1 (en) 2012-07-26 2020-12-22 Verily Life Sciences Llc Employing optical signals for power and/or communication
US10120203B2 (en) 2012-07-26 2018-11-06 Verliy Life Sciences LLC Contact lenses with hybrid power sources
US8864305B2 (en) 2012-07-26 2014-10-21 Google Inc. Facilitation of contact lenses with capacitive sensors
US9158133B1 (en) 2012-07-26 2015-10-13 Google Inc. Contact lens employing optical signals for power and/or communication
US9735892B1 (en) 2012-07-26 2017-08-15 Verily Life Sciences Llc Employing optical signals for power and/or communication
US8857981B2 (en) 2012-07-26 2014-10-14 Google Inc. Facilitation of contact lenses with capacitive sensors
US9298020B1 (en) 2012-07-26 2016-03-29 Verily Life Sciences Llc Input system
US9523865B2 (en) 2012-07-26 2016-12-20 Verily Life Sciences Llc Contact lenses with hybrid power sources
US10256919B1 (en) 2012-07-26 2019-04-09 Verily Life Sciences Llc Employing optical signals for power and/or communication
US8919953B1 (en) 2012-08-02 2014-12-30 Google Inc. Actuatable contact lenses
US9696564B1 (en) 2012-08-21 2017-07-04 Verily Life Sciences Llc Contact lens with metal portion and polymer layer having indentations
US9111473B1 (en) 2012-08-24 2015-08-18 Google Inc. Input system
US8820934B1 (en) 2012-09-05 2014-09-02 Google Inc. Passive surface acoustic wave communication
US9320460B2 (en) 2012-09-07 2016-04-26 Verily Life Sciences Llc In-situ tear sample collection and testing using a contact lens
US9737248B1 (en) 2012-09-11 2017-08-22 Verily Life Sciences Llc Cancellation of a baseline current signal via current subtraction within a linear relaxation oscillator-based current-to-frequency converter circuit
US9398868B1 (en) 2012-09-11 2016-07-26 Verily Life Sciences Llc Cancellation of a baseline current signal via current subtraction within a linear relaxation oscillator-based current-to-frequency converter circuit
US10729363B1 (en) 2012-09-11 2020-08-04 Verily Life Sciences Llc Cancellation of a baseline current signal via current subtraction within a linear relaxation oscillator-based current-to-frequency converter circuit
US10932695B2 (en) 2012-09-17 2021-03-02 Verily Life Sciences Llc Sensing system
US10010270B2 (en) 2012-09-17 2018-07-03 Verily Life Sciences Llc Sensing system
US9326710B1 (en) 2012-09-20 2016-05-03 Verily Life Sciences Llc Contact lenses having sensors with adjustable sensitivity
US8870370B1 (en) 2012-09-24 2014-10-28 Google Inc. Contact lens that facilitates antenna communication via sensor impedance modulation
US8960898B1 (en) 2012-09-24 2015-02-24 Google Inc. Contact lens that restricts incoming light to the eye
US8979271B2 (en) 2012-09-25 2015-03-17 Google Inc. Facilitation of temperature compensation for contact lens sensors and temperature sensing
US9965583B2 (en) 2012-09-25 2018-05-08 Verily Life Sciences, LLC Information processing method
US8989834B2 (en) 2012-09-25 2015-03-24 Google Inc. Wearable device
US9884180B1 (en) 2012-09-26 2018-02-06 Verily Life Sciences Llc Power transducer for a retinal implant using a contact lens
US9054079B2 (en) 2012-09-26 2015-06-09 Google Inc. Assembling thin silicon chips on a contact lens
US10099049B2 (en) 2012-09-26 2018-10-16 Verily Life Sciences Llc Power transducer for a retinal implant using using a contact lens
US8985763B1 (en) 2012-09-26 2015-03-24 Google Inc. Contact lens having an uneven embedded substrate and method of manufacture
US8960899B2 (en) 2012-09-26 2015-02-24 Google Inc. Assembling thin silicon chips on a contact lens
US8821811B2 (en) 2012-09-26 2014-09-02 Google Inc. In-vitro contact lens testing
US9488853B2 (en) 2012-09-26 2016-11-08 Verily Life Sciences Llc Assembly bonding
US9063351B1 (en) 2012-09-28 2015-06-23 Google Inc. Input detection system
US9775513B1 (en) 2012-09-28 2017-10-03 Verily Life Sciences Llc Input detection system
US10342424B2 (en) 2012-09-28 2019-07-09 Verily Life Sciences Llc Input detection system
US8965478B2 (en) 2012-10-12 2015-02-24 Google Inc. Microelectrodes in an ophthalmic electrochemical sensor
US9724027B2 (en) 2012-10-12 2017-08-08 Verily Life Sciences Llc Microelectrodes in an ophthalmic electrochemical sensor
US9055902B2 (en) 2012-10-12 2015-06-16 Google Inc. Microelectrodes in an ophthalmic electrochemical sensor
US9176332B1 (en) 2012-10-24 2015-11-03 Google Inc. Contact lens and method of manufacture to improve sensor sensitivity
US9757056B1 (en) 2012-10-26 2017-09-12 Verily Life Sciences Llc Over-molding of sensor apparatus in eye-mountable device
US8886275B2 (en) 2013-01-15 2014-11-11 Google Inc. Encapsulated electronics
US8874182B2 (en) 2013-01-15 2014-10-28 Google Inc. Encapsulated electronics
US10004457B2 (en) 2013-01-15 2018-06-26 Verily Life Sciences Llc Encapsulated electronics
US9289954B2 (en) 2013-01-17 2016-03-22 Verily Life Sciences Llc Method of ring-shaped structure placement in an eye-mountable device
US8926809B2 (en) 2013-01-25 2015-01-06 Google Inc. Standby biasing of electrochemical sensor to reduce sensor stabilization time during measurement
US9636016B1 (en) 2013-01-25 2017-05-02 Verily Life Sciences Llc Eye-mountable devices and methods for accurately placing a flexible ring containing electronics in eye-mountable devices
US9161712B2 (en) 2013-03-26 2015-10-20 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US8950068B2 (en) 2013-03-26 2015-02-10 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US9009958B2 (en) 2013-03-27 2015-04-21 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US9113829B2 (en) 2013-03-27 2015-08-25 Google Inc. Systems and methods for encapsulating electronics in a mountable device
US9332935B2 (en) 2013-06-14 2016-05-10 Verily Life Sciences Llc Device having embedded antenna
US8880139B1 (en) 2013-06-17 2014-11-04 Google Inc. Symmetrically arranged sensor electrodes in an ophthalmic electrochemical sensor
US9084561B2 (en) 2013-06-17 2015-07-21 Google Inc. Symmetrically arranged sensor electrodes in an ophthalmic electrochemical sensor
US9662054B2 (en) 2013-06-17 2017-05-30 Verily Life Sciences Llc Symmetrically arranged sensor electrodes in an ophthalmic electrochemical sensor
US9948895B1 (en) 2013-06-18 2018-04-17 Verily Life Sciences Llc Fully integrated pinhole camera for eye-mountable imaging system
US9685689B1 (en) 2013-06-27 2017-06-20 Verily Life Sciences Llc Fabrication methods for bio-compatible devices
US9814387B2 (en) 2013-06-28 2017-11-14 Verily Life Sciences, LLC Device identification
US9028772B2 (en) 2013-06-28 2015-05-12 Google Inc. Methods for forming a channel through a polymer layer using one or more photoresist layers
US9307901B1 (en) 2013-06-28 2016-04-12 Verily Life Sciences Llc Methods for leaving a channel in a polymer layer using a cross-linked polymer plug
US9492118B1 (en) 2013-06-28 2016-11-15 Life Sciences Llc Pre-treatment process for electrochemical amperometric sensor
US9654674B1 (en) 2013-12-20 2017-05-16 Verily Life Sciences Llc Image sensor with a plurality of light channels
US9572522B2 (en) 2013-12-20 2017-02-21 Verily Life Sciences Llc Tear fluid conductivity sensor
US9366570B1 (en) 2014-03-10 2016-06-14 Verily Life Sciences Llc Photodiode operable in photoconductive mode and photovoltaic mode
US9184698B1 (en) 2014-03-11 2015-11-10 Google Inc. Reference frequency from ambient light signal
US9789655B1 (en) 2014-03-14 2017-10-17 Verily Life Sciences Llc Methods for mold release of body-mountable devices including microelectronics
US20220096405A1 (en) * 2015-12-07 2022-03-31 General Oncology, Inc. Combination Therapy for Metastatic Cancer
US10799421B2 (en) 2016-03-09 2020-10-13 Equinox Ophthalmic, Inc. Therapeutic eye treatment with gases
US11730671B2 (en) 2016-03-09 2023-08-22 Equinox Ophthalmic, Inc. Therapeutic eye treatment with gases

Also Published As

Publication number Publication date
EP0293169A1 (en) 1988-11-30
EP0293169B1 (en) 1993-04-21
DE3880372T2 (en) 1993-07-29
DE3880372D1 (en) 1993-05-27
CA1305873C (en) 1992-08-04
JPS6476832A (en) 1989-03-22

Similar Documents

Publication Publication Date Title
US4997770A (en) Method and means for detecting blood alcohol in humans by testing vapor above the eye
Døssing et al. A simple method for determination of antipyrine clearance
Farris et al. Basal and reflex human tear analysis: I. Physical measurements: osmolarity, basal volumes, and reflex flow rate
Chadwick et al. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400): II. Application to normal and abnormal permeability states in man and animals
Borkenstein et al. The breathalyzer and its applications
Mucklow The use of saliva in therapeutic drug monitoring
Šedivec et al. Biological monitoring of persons exposed to methanol vapours
Williams et al. Dynamic measurement of human capillary blood pressure
Dab et al. A simplified approach to the measurement of specific airway resistance
Miller et al. A comparison of the cardiac output determination by the direct Fick method and the dye-dilution method using indocyanine green dye and a cuvette densitometer
Bermejo et al. Determination of malonaldehyde in Alzheimer’s disease: a comparative study of high-performance liquid chromatography and thiobarbituric acid test
Knott Excretion of drugs into saliva
Sanaka et al. Comparison between gastric scintigraphy and the [13C]‐acetate breath test with Wagner–Nelson analysis in humans
Sharp et al. Pharmacoepidemiology of the effect of caffeine on blood pressure
Jones Electrochemical measurement of breath-alcohol concentration: precision and accuracy in relation to blood levels
Nelson et al. Noninvasive arterial monitor for quantitative oxygen-15-water blood flow studies
Mark et al. Continuous arterial and venous blood gas monitoring during cardiopulmonary bypass
Wyse et al. Measurement of cardiac output by thermal dilution in infants and children.
Deacon et al. Measurement of pulse oximetry, capnography and pH
Fox et al. Effect of hyperthermia on breath-alcohol analysis
Stewart et al. Emergency estimations of paraquat in plasma. A comparison of the RIA and ion pair/colorimetric methods
Jones Evaluation of breath alcohol instruments II. In vivo experiments with Alcolmeter Pocket Model
Jones The analysis of ethanol in blood and breath for legal purposes: A historical review
Palm et al. Optimized atomic absorption spectrophotometry of zinc in cerebrospinal fluid.
Peters Studies on the metabolism of isoniazid: II. The influence of para-aminosalicylic acid on the metabolism of isoniazid by man

Legal Events

Date Code Title Description
AS Assignment

Owner name: ALCOHOLISM AND DRUG ADDICTION RESEARCH FOUNDATION,

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:GILES, HOWEL G.;ISRAEL, YEDY;REEL/FRAME:004861/0011

Effective date: 19880107

Owner name: ALCOHOLISM AND DRUG ADDICTION RESEARCH FOUNDATION,

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GILES, HOWEL G.;ISRAEL, YEDY;REEL/FRAME:004861/0011

Effective date: 19880107

FEPP Fee payment procedure

Free format text: PAT HLDR NO LONGER CLAIMS SMALL ENT STAT AS INDIV INVENTOR (ORIGINAL EVENT CODE: LSM1); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 19990305

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362